BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30387011)

  • 1. Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant review.
    Mishra A; Jaiswal R; Amita P; Mishra SC
    Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):93-100. PubMed ID: 30387011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlation of molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) expression in juvenile nasopharyngeal angiofibroma.
    Mishra A; Mishra SC; Tripathi AM; Pandey A
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2719-2726. PubMed ID: 30171340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current molecular profile of juvenile nasopharyngeal angiofibroma: First comprehensive study from India.
    Pandey P; Mishra A; Tripathi AM; Verma V; Trivedi R; Singh HP; Kumar S; Patel B; Singh V; Pandey S; Pandey A; Mishra SC
    Laryngoscope; 2017 Mar; 127(3):E100-E106. PubMed ID: 27577998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of growth factors, proto-oncogenes, and p53 in nasopharyngeal angiofibromas.
    Nagai MA; Butugan O; Logullo A; Brentani MM
    Laryngoscope; 1996 Feb; 106(2 Pt 1):190-5. PubMed ID: 8583852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of tumor-infiltrating IL-17-producing cells in juvenile nasopharyngeal angiofibroma tumor microenvironment is a poor prognostic factor.
    Sun X; Guo L; Wang H; Yu H; Wang J; Meng X; Liu Z; Liu J; Hu L; Li H; Wang D
    Am J Otolaryngol; 2014; 35(5):582-8. PubMed ID: 25014998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-Inducible Factor-1α (HIF-1α) Expression on Endothelial Cells in Juvenile Nasopharyngeal Angiofibroma: A Review of 70 cases and Tissue Microarray Analysis.
    Song X; Yang C; Zhang H; Wang J; Sun X; Hu L; Liu Z; Wang D
    Ann Otol Rhinol Laryngol; 2018 Jun; 127(6):357-366. PubMed ID: 29717655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma: immunohistochemical and tissue microarray analysis.
    Liu Z; Wang J; Wang H; Wang D; Hu L; Liu Q; Sun X
    Acta Otolaryngol; 2015 Jan; 135(1):51-7. PubMed ID: 25384380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma--do they have a role?
    Renkonen S; Häyry V; Heikkilä P; Leivo I; Haglund C; Mäkitie AA; Hagström J
    Virchows Arch; 2011 Feb; 458(2):189-95. PubMed ID: 21113618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: an immunohistochemical study.
    Zhang M; Sun X; Yu H; Hu L; Wang D
    Acta Histochem; 2011 Oct; 113(6):626-30. PubMed ID: 20688360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenascin-C, GLUT-1, and syndecan-2 expression in juvenile nasopharyngeal angiofibroma: correlations to vessel density and tumor stage.
    Renkonen S; Heikkilä P; Haglund C; Mäkitie AA; Hagström J
    Head Neck; 2013 Jul; 35(7):1036-42. PubMed ID: 22791513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of PCNA, VEGF and bFGF in endothelial cells of juvenile nasopharyngeal angiofibroma].
    Sun Y; Wu Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Dec; 20(23):1076-8. PubMed ID: 17285972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Genetic and Molecular Determinants of Juvenile Nasopharyngeal Angiofibroma: A Systematic Review.
    Doody J; Adil EA; Trenor CC; Cunningham MJ
    Ann Otol Rhinol Laryngol; 2019 Nov; 128(11):1061-1072. PubMed ID: 31148463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma.
    Le T; New J; Jones JW; Usman S; Yalamanchali S; Tawfik O; Hoover L; Bruegger DE; Thomas SM
    Int Forum Allergy Rhinol; 2017 Oct; 7(10):973-979. PubMed ID: 28707818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma.
    Saylam G; Yücel OT; Sungur A; Onerci M
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):227-34. PubMed ID: 16023739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: tissue microarray analysis and association with prognostic significance.
    Wang JJ; Sun XC; Hu L; Liu ZF; Yu HP; Li H; Wang SY; Wang DH
    Head Neck; 2013 Dec; 35(12):1719-25. PubMed ID: 23471755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papilloma virus in Juvenile Nasopharyngeal Angiofibroma: possible recent trend.
    Mishra A; Sachadeva M; Jain A; Shukla NM; Pandey A
    Am J Otolaryngol; 2016; 37(4):317-22. PubMed ID: 27157983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA).
    Ponti G; Losi L; Pellacani G; Rossi GB; Presutti L; Mattioli F; Villari D; Wannesson L; Alicandri Ciufelli M; Izzo P; De Rosa M; Marone P; Seidenari S
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):173-8. PubMed ID: 18227724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas.
    Brieger J; Wierzbicka M; Sokolov M; Roth Y; Szyfter W; Mann WJ
    Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):727-31. PubMed ID: 15210553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The isolation and characterization of endothelial cells from juvenile nasopharyngeal angiofibroma.
    Wang J; Liu Z; Hu L; Sun X; Yu H; Zhang H; Yang C; Liu Q; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):856-8. PubMed ID: 27421657
    [No Abstract]   [Full Text] [Related]  

  • 20. FGFR3 and FGFR4 overexpression in juvenile nasopharyngeal angiofibroma: impact of smoking history and implications for personalized management.
    Safhi FA; Al-Hazani TMI; Jalal AS; Alduwish MA; Alshaya DS; Almufareh NA; Domiaty DM; Alshehri E; Al-Shamrani SM; Abboosh TS; Alotaibi MA; Alwaili MA; Al-Qahtani WS
    J Appl Genet; 2023 Dec; 64(4):749-758. PubMed ID: 37656292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.